Millions of U.S. allergy sufferers now have access to advanced diagnostic tests
Millions of undiagnosed allergy sufferers, including those affected by allergy induced asthma, can now access Thermo Fisher’s advanced allergy tests through PlushCare’s trained telehealth physicians in more than 31 states. PlushCare fills a growing access-to-care gap in healthcare. The Association of American Medical Colleges estimates there will be a shortage of between 40,800 and 104,900 physicians by 2030.
Undiagnosed patients who visit www.plushcare.com/testing/allergy consult with qualified physicians, all trained at top-50 U.S. medical institutions, who can order appropriate allergy tests, if necessary. Patients can then schedule testing locally at a participating lab partner, after which they’ll review results with the telehealth physician, all without setting foot in a doctor’s office. Everything, except for the actual test, can be done using a smartphone or computer. Patients can also learn more about allergy and testing by starting their journey at www.allergy-insider.com.
PlushCare is helping to modernize healthcare by connecting patients with same-day medical care through mobile and desktop devices. The company believes that many existing patient conditions would be treatable via telehealth, and the company cites American Medical Association estimates that up to 70% of all doctor, urgent care, and emergency room visits are either unnecessary or could be handled safely and effectively online.
Convenient access to advanced testing through PlushCare gives more patients an opportunity to benefit from proven in vitro allergy diagnostics: Thermo Fisher supplies seven out of 10 allergy laboratory tests worldwide. These tests can identify allergic sensitization to common environmental allergens—seasonal and perennial, indoor and outdoor—in the states served by PlushCare’s physicians. ImmunoCAP Specific IgE blood tests are fast and easy to administer to patients of any age regardless of skin condition, current medication, symptom, disease activity, or pregnancy status.
PlushCare is available in 31 states and has plans to be in all states in 2018.
